Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982;13(Suppl 2):345S–351S. doi: 10.1111/j.1365-2125.1982.tb01939.x

Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.

R E Rangno, S Langlois
PMCID: PMC1402152  PMID: 6125187

Abstract

1 After abrupt propranolol withdrawal a rebound increase in cardiac sensitivity to isoprenaline occurred in 9/9 patients and persisted up to 14 days. A mild brief rebound in resting heart rate occurred in 4/9 patients and a rebound in blood pressure occurred in 6/9 patients. These withdrawal phenomena were prevented by gradual withdrawal on a prolonged small dose of propranolol. 2 After abrupt metoprolol withdrawal a rebound increase in cardiac sensitivity to isoprenaline occurred in 8/8 patients but had resolved by 8 days. A marked persistent rebound in resting heart rate occurred in 8/8 patients while a small brief rebound in blood pressure occurred in only one patient. These withdrawal phenomena were largely prevented by gradual withdrawal on a prolonged small dose of metoprolol. 3 After abrupt pindolol withdrawal there was no rebound in isoprenaline sensitivity but a mild brief rebound in resting heart rate occurred in 9/10 patients. There was no rebound in blood pressure. 4 The type, magnitude and frequency of withdrawal phenomena after various beta-adrenergic receptor blockers probably reflects substantial differences in their basic pharmacological characteristics. 5 Caution must be exercised when withdrawing any patient from any beta-adrenoceptor blocker since an adverse cardiac event is unpredictable.

Full text

PDF
349S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarons R. D., Nies A. S., Gal J., Hegstrand L. R., Molinoff P. B. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest. 1980 May;65(5):949–957. doi: 10.1172/JCI109781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baker S. P., Boyd H. M., Potter L. T. Distribution and function of beta-adrenoceptors in different chambers of the canine heart. Br J Pharmacol. 1980 Jan;68(1):57–63. doi: 10.1111/j.1476-5381.1980.tb10698.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bryan L. J., Cole J. J., O'Donnell S. R., Wanstall J. C. A study designed to explore the hypothesis that beta-1 adrenoceptors are "innervated" receptors and beta-2 adrenoceptors are "hormonal" receptors. J Pharmacol Exp Ther. 1981 Feb;216(2):395–400. [PubMed] [Google Scholar]
  4. Cleaveland C. R., Rangno R. E., Shand D. G. A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol. Arch Intern Med. 1972 Jul;130(1):47–52. doi: 10.1001/archinte.130.1.47. [DOI] [PubMed] [Google Scholar]
  5. Frishman W., Kostis J., Strom J., Hossler M., Elkayam U., Goldner S., Silverman R., Davis R., Weinstein J., Sonnenblick E. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity. Am Heart J. 1979 Oct;98(4):526–535. doi: 10.1016/0002-8703(79)90261-8. [DOI] [PubMed] [Google Scholar]
  6. Galant S. P., Duriseti L., Underwood S., Insel P. A. Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Engl J Med. 1978 Oct 26;299(17):933–936. doi: 10.1056/NEJM197810262991707. [DOI] [PubMed] [Google Scholar]
  7. Gerber J. G., Nies A. S. Abrupt withdrawal of cardiovascular drugs. N Engl J Med. 1979 Nov 29;301(22):1234–1235. doi: 10.1056/NEJM197911293012210. [DOI] [PubMed] [Google Scholar]
  8. Glaubiger G., Lefkowitz R. J. Elevated beta-adrenergic receptor number after chronic propranolol treatment. Biochem Biophys Res Commun. 1977 Sep 23;78(2):720–725. doi: 10.1016/0006-291x(77)90238-8. [DOI] [PubMed] [Google Scholar]
  9. Lewis M. J., Ross P. J., Henderson A. H. Rebound effect after stopping beta-blockers. Br Med J. 1979 Sep 8;2(6190):606–606. doi: 10.1136/bmj.2.6190.606-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Miller R. R., Olson H. G., Amsterdam E. A., Mason D. T. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975 Aug 28;293(9):416–418. doi: 10.1056/NEJM197508282930902. [DOI] [PubMed] [Google Scholar]
  11. Mizgala H. F., Counsell J. Acute coronary syndromes following abrupt cessation of oral propranolol therapy. Can Med Assoc J. 1976 Jun 19;114(12):1123–1126. [PMC free article] [PubMed] [Google Scholar]
  12. Nattel S., Rangno R. E., Van Loon G. Mechanism of propranolol withdrawal phenomena. Circulation. 1979 Jun;59(6):1158–1164. doi: 10.1161/01.cir.59.6.1158. [DOI] [PubMed] [Google Scholar]
  13. Nattel S., Shanks J., Rangno R. E. Propranolol withdrawal. Ann Intern Med. 1978 Aug;89(2):288–288. doi: 10.7326/0003-4819-89-2-288_2. [DOI] [PubMed] [Google Scholar]
  14. O'Brien E. T., MacKinnon J. Propranolol and polythiazide in treatment of hypertension. Br Heart J. 1972 Oct;34(10):1042–1044. doi: 10.1136/hrt.34.10.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rangno R. E., Langlois S., Lutterodt A. Metoprolol withdrawal phenomena: mechanism and prevention. Clin Pharmacol Ther. 1982 Jan;31(1):8–15. doi: 10.1038/clpt.1982.2. [DOI] [PubMed] [Google Scholar]
  16. Robinson B. F. Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris. Circulation. 1967 Jun;35(6):1073–1083. doi: 10.1161/01.cir.35.6.1073. [DOI] [PubMed] [Google Scholar]
  17. Shand D. G., Wood A. J. Propranolol withdrawal syndrome - why? Circulation. 1978 Aug;58(2):202–203. doi: 10.1161/01.cir.58.2.202. [DOI] [PubMed] [Google Scholar]
  18. Wolfe B. B., Harden T. K., Molinoff P. B. In vitro study of beta-adrenergic receptors. Annu Rev Pharmacol Toxicol. 1977;17:575–604. doi: 10.1146/annurev.pa.17.040177.003043. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES